India’s Draft Pharma Policy Could Pass On April 30
This article was originally published in PharmAsia News
Executive Summary
NEW DELHI - The much-delayed draft pharmaceutical policy for India could be finalized by the end of the month, government sources told PharmAsia News.
You may also be interested in...
Pressure Rises To Pass India’s Draft Drug Policy
NEW DELHI - Indian Chemicals Minister Ram Vilas Paswan is making an all out effort to get the country's draft pharmaceutical policy cleared by the Group of Ministers in its next meeting
IP Protection Concerns Grow In India, PhRMA Says
Intellectual property protection in India is an increasing concern for industry following a year of regulatory action and inaction, according to the Pharmaceutical Research and Manufacturers of America
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).